News und Analysen

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the Credit Suisse 29^th Annual Virtual Healthcare Conference, which is being held on November 9 -

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced that data from

Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the 29^th Annual Credit

Novocure (NASDAQ:NVCR), a global oncology company striving to extend survival in some of the most aggressive forms of cancer, today announced the pricing of $500 million aggregate principal amount

Premier, Inc. (NASDAQ: PINC) today reported financial results for the fiscal year (FY) 2021 first quarter ended September 30, 2020.

All results presented in this press release reflect continuing

Novocure (NASDAQ: NVCR), a global oncology company striving to extend survival in some of the most aggressive forms of cancer, today announced its intention to offer $500 million aggregate

Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune disease, today announced that it will

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the quarter ended September 30, 2020, and provided guidance for the fourth quarter of 2020.

The Company

Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2020. For the quarter, revenue was $743.3 million, an increase of 11.3% from $668.0

Novocure (NASDAQ: NVCR) today reported financial results for the quarter ended September 30, 2020, highlighting revenue growth and financial strength as well as the advancement of the company’s

Novocure (NASDAQ: NVCR) today announced it has entered into a strategic alliance with the NYU Grossman School of Medicine’s Department of Radiation Oncology that provides a framework for

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that Michael J. Fucci has been appointed to serve as an independent director on its Board of Directors. Mr. Fucci’s appointment, which

Call to Freedom, a nonprofit organization focused on navigating a healthy path for victims of human trafficking, has received the 28^th annual Monroe E. Trout Premier Cares Award and a $100,000 cash

Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement company, today announced that its Board of Directors declared a cash dividend of $0.19 per share of Class A common stock issued and

Premier Inc. (NASDAQ: PINC), through its ProvideGx^® program, has partnered with Baxter Healthcare to supply pre-filled, single-use IV bags of dexmedetomidine hydrochloride to healthcare providers

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of George Llado, Senior Vice President and Chief Information Officer of Alexion Pharmaceuticals, Inc., to

Premier Inc. (NASDAQ: PINC) today announced a new, two-year, $8 million national partnership with the U.S. Department of Health and Human Services (HHS) Office of Women’s Health to leverage

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies for the treatment of cancer and autoimmune diseases, today announced four poster

Premier, Inc. (NASDAQ: PINC) today announced that it will release financial results for its fiscal 2021 first quarter on Monday, November 2, 2020, at approximately 4:15 p.m. ET. The company will

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2020 financial results on Thursday, October 29^th, before the market opens. A conference call has been scheduled

Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2020, on Thursday, October 29, 2020, following the close of trading on

AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations, has scheduled a conference call to discuss its third quarter 2020

AMN Healthcare Services, Inc. (NYSE: AMN) announced today that its wholly owned subsidiary, AMN Healthcare, Inc., priced its previously announced private offering of $350.0 million aggregate

AMN Healthcare (NYSE:AMN) announces the appointment to its Board of Directors of Rear Admiral Sylvia Trent-Adams, PhD, RN, FAAN, a distinguished leader in the U.S. Public Health Service